Overlapping autoimmunity and demyelination syndromes associated with TNF inhibitor therapy
Clinical Rheumatology · 2026
DOI: 10.1007/s10067-026-07976-5 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Rheumatology, 2026. Verfasst von Rula Daood und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Galilee Medical Center, Nahariya, Israel. rula.daood@gmail.com. Hauptthemen laut MEDLINE: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Adalimumab, Spondylitis, Ankylosing, Lupus Erythematosus, Systemic. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a demyelinating disorder of the central nervous system. We describe a case of a 31-year-old male with ankylosing spondylitis who developed optic neuritis and transverse myelitis accompanied by positive anti-MOG antibodies, and subsequently features consistent with systemic lupus erythematosus (SLE), beginning 3 months after initiating adalimumab. Adalimumab was discontinued, and the patient was treated with pulsed intravenous methylprednisolone followed by rituximab with significant improvement in clinical, imaging, and laboratory manifestations of the disease. This case highlights a rare constellation of overlapping autoimmune diseases, with both MOGAD and SLE emerging after anti-TNF antibody exposure in a patient with ankylosing spondylitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology Unit, Galilee Medical Center, Nahariya, Israel. rula.daood@gmail.com.
- Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel. rula.daood@gmail.com.
- Rheumatology Unit, Galilee Medical Center, Nahariya, Israel.
- Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
- Neurology Department, Galilee Medical Center, Nahariya, Israel.
Zitieren
APA
Daood, R., Naffaa, M. E., Azrilin, O., Hassan, F., Jeries, H., & Chaim, P. (2026). Overlapping autoimmunity and demyelination syndromes associated with TNF inhibitor therapy. Clinical Rheumatology. https://doi.org/10.1007/s10067-026-07976-5
Vancouver
Daood R, Naffaa ME, Azrilin O, Hassan F, Jeries H, Chaim P. Overlapping autoimmunity and demyelination syndromes associated with TNF inhibitor therapy. Clinical Rheumatology. 2026. doi:10.1007/s10067-026-07976-5
BibTeX
@article{Daood2026,
author = {Daood, Rula and Naffaa, Mohammad E and Azrilin, Olga and Hassan, Fadi and Jeries, Helana and Chaim, Putterman},
title = {Overlapping autoimmunity and demyelination syndromes associated with TNF inhibitor therapy},
journal = {Clinical Rheumatology},
year = {2026},
doi = {10.1007/s10067-026-07976-5}
}
EUVIMED